Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 781 AL 795

Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials

Espay AJ, Schwarzschild MA, Tanner CM, Fernandez HH, Simon DK, Leverenz JB, Merola A, Chen-Plotkin A, Brundin P, Kauffman MA, Erro R, Kieburtz K, Woo D, Macklin EA, Standaert DG, Lang AE.

Mov Disord. 2017 Mar;32(3):319-324. doi: 10.1002/mds.26913. Epub 2017 Feb 24.

Are Dopamine Oxidation Metabolites Involved in the Loss of Dopaminergic Neurons in the Nigrostriatal System in Parkinson's Disease?

Herrera A, Muñoz P, Steinbusch HWM, Segura-Aguilar J.

ACS Chem Neurosci. 2017 Apr 19;8(4):702-711. doi: 10.1021/acschemneuro.7b00034. Epub 2017 Mar 3.

Opicapone for the treatment of Parkinson's disease

Rodrigues FB, Ferreira JJ.

Expert Opin Pharmacother. 2017 Mar;18(4):445-453. doi: 10.1080/14656566.2017.1294683. Epub 2017 Feb 22.

Increased frequency of multiple sclerosis among patients with bullous pemphigoid: a population-based cohort study on comorbidities anchored around the diagnosis of bullous pemphigoid

Kibsgaard L, Rasmussen M, Lamberg A, Deleuran M, Olesen AB, Vestergaard C.

Br J Dermatol. 2017 Jun;176(6):1486-1491. doi: 10.1111/bjd.15405. Epub 2017 Apr 10.

Mitophagy in neurodegeneration and aging

Fivenson EM, Lautrup S, Sun N, Scheibye-Knudsen M, Stevnsner T, Nilsen H, Bohr VA, Fang EF.

Neurochem Int. 2017 Oct;109:202-209. doi: 10.1016/j.neuint.2017.02.007. Epub 2017 Feb 21.

Clinical evoked potentials in neurology: a review of techniques and indications

Lascano AM, Lalive PH, Hardmeier M, Fuhr P, Seeck M.

J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):688-696. doi: 10.1136/jnnp-2016-314791. Epub 2017 Feb 24.

Post-stroke totally recovery of tremor in a patient with Parkinson's disease

Onder H, Saka E.

Neurol Sci. 2017 Jun;38(6):1127-1128. doi: 10.1007/s10072-017-2869-x. Epub 2017 Feb 24.

Pharmacokinetics of Rytary(®), An Extended-Release Capsule Formulation of Carbidopa-Levodopa

Mittur A, Gupta S, Modi NB.

Clin Pharmacokinet. 2017 Sep;56(9):999-1014. doi: 10.1007/s40262-017-0511-y.

A randomized trial of relamorelin for constipation in Parkinson's disease (MOVE-PD): Trial results and lessons learned

Parkinson Study Group. Electronic address: pfeiffro@ohsu.edu.

Parkinsonism Relat Disord. 2017 Apr;37:101-105. doi: 10.1016/j.parkreldis.2017.02.003. Epub 2017 Feb 14.

Globus pallidus internus deep brain stimulation in PINK-1 related Parkinson's disease: A case report

Borellini L, Cogiamanian F, Carrabba G, Locatelli M, Rampini P, Di Fonzo A, Bana C, Barbieri S, Ardolino G.

Parkinsonism Relat Disord. 2017 May;38:93-94. doi: 10.1016/j.parkreldis.2017.02.018. Epub 2017 Feb 20.

Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up

Sensi M, Cossu G, Mancini F, Pilleri M, Zibetti M, Modugno N, Quatrale R, Tamma F, Antonini A; ITALIAN LEVODOPA CARBIDOPA INTESTINAL GEL WORKING GROUP.

Parkinsonism Relat Disord. 2017 May;38:90-92. doi: 10.1016/j.parkreldis.2017.02.020. Epub 2017 Feb 21.

Genetic Determinants of Parkinson's Disease: Can They Help to Stratify the Patients Based on the Underlying Molecular Defect?

Redenšek S, Trošt M, Dolžan V.

Front Aging Neurosci. 2017 Feb 10;9:20. doi: 10.3389/fnagi.2017.00020. eCollection 2017.

The underlying mechanism of prodromal PD: insights from the parasympathetic nervous system and the olfactory system

Liu SY, Chan P, Stoessl AJ.

Transl Neurodegener. 2017 Feb 20;6:4. doi: 10.1186/s40035-017-0074-8. eCollection 2017.

The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents

Murillo-Rodriguez E, Pastrana-Trejo JC, Salas-Crisóstomo M, de-la-Cruz M.

CNS Neurol Disord Drug Targets. 2017;16(4):370-379. doi: 10.2174/1871527316666170223161908.

Timed Light Therapy for Sleep and Daytime Sleepiness Associated With Parkinson Disease: A Randomized Clinical Trial

Videnovic A, Klerman EB, Wang W, Marconi A, Kuhta T, Zee PC.

JAMA Neurol. 2017 Apr 1;74(4):411-418. doi: 10.1001/jamaneurol.2016.5192.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias